Bhubaneswar: The Odisha government on Saturday (June 12) ordered a probe into the alleged circulation of ‘pretend’ COVID-19 medicines, officers stated.
The government additionally determined to provoke authorized motion towards these accountable for supplying “spurious COVID-19 medicines” seized within the final two days, they stated.
Health and Family Welfare Department’s Additional Chief Secretary PK Mohapatra issued a course to the Odisha State Medical Corporation Ltd and the police to launch a joint inquiry into the seizure of alleged spurious medication and submit a report.
“Prosecution cases will be started in the specially designated courts under the provisions of the Drugs and Cosmetics Act,” he stated.
The authorities had seized a big amount of “spurious” Favipiravir tablets in Cuttack on June 10.
They additionally recovered “fake” medication somewhere else, together with Bhubaneswar, on Friday (June 10).
“Seizures were made in Bolangir, Jharsuguda, Sambalpur, Rourkela and Bhubaneswar on June 11,” the officers stated.
Acting on a tip-off from the Food and Drugs Administration, Maharashtra on spurious Favipiravir tablets allegedly manufactured by an organization in
In Himachal Pradesh, the authorities in Odisha initiated actions. These medicines have been bought by an organization in Cuttack, they stated.
“A raid was conducted on the premises of the buyer firm by the Cuttack drugs inspectors,” an official stated.
The inspectors additionally discovered the producer of the medicine was a non-existing entity, he stated, including that throughout the raid, it was famous that the Cuttack-based firm had bought 58,000 “Favimax-400” tablets from an entity situated at Gautam Budh Nagar in Uttar Pradesh.
Of the bought amount, the Cuttack-based purchaser equipped 40,600 tablets to a different entity in Gwalior in Madhya Pradesh.
Of the obtainable inventory of 17,400 tablets, 400 have been taken for statutory testing and the remaining ones have been seized below the supply of the Drugs & Cosmetics Act and Rules, the official stated.
The provide particulars of “Favimax-400” tablets to Gwalior have been communicated to the Food and Drugs Administration, Madhya Pradesh.
Nine different medication allegedly manufactured by the identical entity have additionally been bought by the Cuttack-based agency.
To verify the authenticity of those medication and assess their high quality, statutory samples of those 9 medication have been taken and stability shares have been seized, one other official stated.
Meanwhile, the Utkal Chemist and Druggist Association secretary Prasant Mohapatra stated anybody discovered responsible of circulating spurious medicines throughout the pandemic needs to be punished.
ALSO READ: Monsoon to achieve Bihar, Jharkhand, West Bengal, Odisha by June 15, predicts IMD
